Tauns Laboratories, Inc. (JP:197A) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tauns Laboratories, Inc. reports a robust financial performance for FY2024, with significant increases in net income by 90.3%, operating income by 61.7%, and net sales by 17.6% compared to the previous fiscal year. The company also projects continued growth in FY2025 with a 4.5% rise in net sales and a 4.2% increase in net income. Additionally, Tauns Laboratories has announced a substantial year-end dividend of 27.75 yen per share for FY2024, reflecting a confident outlook.
For further insights into JP:197A stock, check out TipRanks’ Stock Analysis page.